Search Within

Results 1 - 15 of 15
Understanding the Mechanism of Platelet Thrombus Formation under Blood Flow Conditions and the Effect of New Antiplatelet Agents

Journal: Current Vascular Pharmacology
Volume: 2,Issue: 1
Page: 23-32
Authors: Shinya Goto

Understanding the Mechanism and Prevention of Arterial Occlusive Thrombus Formation by Anti-Platelet Agents

Journal: Current Medicinal Chemistry-Cardiovascular & Hematological Agents
Volume: 2,Issue: 2
Page: 149-156
Authors: S. Goto

Collagen Receptors as Potential Targets for Novel Anti-Platelet Agents

Journal: Current Pharmaceutical Design
Volume: 13,Issue: 26
Page: 2673-2683
Authors: Kenneth J. Clemetson and Jeannine M. Clemetson

Platelet Inhibition Agents: Current and Future P2Y12 Receptor Antagonists

Journal: Current Vascular Pharmacology
Volume: 13,Issue: 5
Page: 566-577
Authors: Jie Tang, Mu-Peng Li, Hong-Hao Zhou and Xiao-Ping Chen

Emerging P2Y12 Receptor Antagonists: Role in Coronary Artery Disease

Journal: Current Vascular Pharmacology
Volume: 8,Issue: 1
Page: 93-101
Authors: Carrie S. Oliphant, J. Bradford Doby, Crystal L. Blade, Kanak Das, Debabrata Mukherjee and Pranab Das

Recent Advances in the Discovery and Development of Direct Coagulation Factor Xa Inhibitors

Journal: Current Pharmaceutical Design
Volume: 9,Issue: 28
Page: 2337-2347
Authors: W. R. Gould and R. J. Leadley

Targeting Platelet G-Protein Coupled Receptors (GPCRs): Looking Beyond Conventional GPCR Antagonism

Journal: Current Vascular Pharmacology
Volume: 8,Issue: 2
Page: 140-154
Authors: Louisa Dowal and Robert Flaumenhaft

Vorapaxar, a Protease-Activated Receptor-1 Antagonist, a Double –Edged Sword!

Journal: Recent Advances in Cardiovascular Drug Discovery (Discontinued)
Volume: 9,Issue: 2
Page: 73-77
Authors: Bharti Bhandari and Bharati Mehta

Intravenous Glycoprotein IIb / IIIa Antagonists: Their Benefits, Problems and Future Developments

Journal: Current Pharmaceutical Design
Volume: 10,Issue: 14
Page: 1577-1585
Authors: Ronan Curtin

Effect of a Hybrid Peptide Derived from Platelet Type I and Type III Collagen Receptors on CHO-65 Cells

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 9,Issue: 3
Page: 167-171
Authors: Thomas M. Chiang

Future Prospects in Anti-Platelet Therapy: A Review of Potential P2Y12 and Thrombin Receptor Antagonists

Journal: Recent Patents on Cardiovascular Drug Discovery (Discontinued)
Volume: 3,Issue: 3
Page: 194-200
Authors: Nicholas B. Norgard and Mazen Abu-Fadel

Advances in Antiplatelet Therapy for Stroke Prevention: the New P2Y12 antagonists

Journal: Current Drug Targets
Volume: 11,Issue: 3
Page: 380-391
Authors: A. Giossi, A. Pezzini, E. Del Zotto, I. Volonghi, P. Costa, D. Ferrari and A. Padovani

Advances in Inhibitors of FXa

Journal: Current Drug Targets
Volume: 16,Issue: 11
Page: 1207-1232
Authors: Liwei Guo and Shutao Ma

Development of Trypsin-Like Serine Protease Inhibitors as Therapeutic Agents: Opportunities, Challenges, and their Unique Structure-Based Rationales

Journal: Current Topics in Medicinal Chemistry
Volume: 16,Issue: 13
Page: 1506-1529
Authors: Guyan Liang and J. Phillip Bowen

P2Y12 Receptor Antagonists: Which One to Choose? A Systematic Review and Meta-Analysis

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 29
Page: 4568-4576
Authors: Alexandros Briasoulis, Tesfaye Telila, Mohan Palla, Gerasimos Siasos and Dimitris Tousoulis

Results 1 - 15 of 15